BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1848677)

  • 1. Neuronal inclusions of Parkinson's disease.
    Gibb WR; Scott T; Lees AJ
    Mov Disord; 1991; 6(1):2-11. PubMed ID: 1848677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies.
    Hill WD; Lee VM; Hurtig HI; Murray JM; Trojanowski JQ
    J Comp Neurol; 1991 Jul; 309(1):150-60. PubMed ID: 1716646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies.
    Tiller-Borcich JK; Forno LS
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):526-35. PubMed ID: 2845001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
    Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
    Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal intranuclear hyaline inclusion disease: report of a case and review of the literature.
    Funata N; Maeda Y; Koike M; Yano Y; Kaseda M; Muro T; Okeda R; Iwata M; Yokoji M
    Clin Neuropathol; 1990; 9(2):89-96. PubMed ID: 1692776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys.
    Forno LS; Langston JW; DeLanney LE; Irwin I; Ricaurte GA
    Ann Neurol; 1986 Oct; 20(4):449-55. PubMed ID: 3024555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lewy bodies, a misleading marker for Parkinson's disease?].
    Duyckaerts C; Hauw JJ
    Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease.
    Baloyannis SJ; Costa V; Baloyannis IS
    J Neurol Sci; 2006 Oct; 248(1-2):35-41. PubMed ID: 16753180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parkinson's disease: the distribution of Lewy bodies in the peripheral autonomic nervous system].
    Wakabayashi K
    No To Shinkei; 1989 Oct; 41(10):965-71. PubMed ID: 2557873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.
    Gibb WR; Fearnley JM; Lees AJ
    Adv Neurol; 1990; 53():31-4. PubMed ID: 2173373
    [No Abstract]   [Full Text] [Related]  

  • 13. Fine structure of neuronal spherical arginine-rich bodies of substantia nigra and locus coeruleus in the human brain.
    Issidorides MR; Pappas GD
    Hum Neurobiol; 1988; 6(4):239-46. PubMed ID: 2832354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.
    Qualman SJ; Haupt HM; Yang P; Hamilton SR
    Gastroenterology; 1984 Oct; 87(4):848-56. PubMed ID: 6088351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit.
    Galvin JE; Lee VM; Baba M; Mann DM; Dickson DW; Yamaguchi H; Schmidt ML; Iwatsubo T; Trojanowski JQ
    Ann Neurol; 1997 Oct; 42(4):595-603. PubMed ID: 9382471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
    Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis.
    Murayama S; Mori H; Ihara Y; Bouldin TW; Suzuki K; Tomonaga M
    Ann Neurol; 1990 Feb; 27(2):137-48. PubMed ID: 2156479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Minimal change" multiple system atrophy.
    Wenning GK; Quinn N; Magalhăes M; Mathias C; Daniel SE
    Mov Disord; 1994 Mar; 9(2):161-6. PubMed ID: 8196676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An autopsy case of multiple system atrophy with many Lewy bodies--striatonigral degeneration, olivo-ponto-cerebellar atrophy and autonomic nerve nucleus involvement in the spinal cord].
    Morioka E; Kuroda S; Kuyama K; Otsuki S; Hosokawa K; Namba R
    No To Shinkei; 1987 Apr; 39(4):361-6. PubMed ID: 3036191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classic and generalized variants of Pick's disease: a clinicopathological, ultrastructural, and immunocytochemical comparative study.
    Munoz-Garcia D; Ludwin SK
    Ann Neurol; 1984 Oct; 16(4):467-80. PubMed ID: 6093681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.